Home Frontmatter
Article Publicly Available

Frontmatter

Published/Copyright: April 1, 2017

Published Online: 2017-4-1
Published in Print: 2017-5-1

©2017 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Not all good things come in big packages
  4. Pre-analytical and Analytical Issues of miRNA Measurement
  5. Variability in, variability out: best practice recommendations to standardize pre-analytical variables in the detection of circulating and tissue microRNAs
  6. Pitfalls of analysis of circulating miRNA: role of hematocrit
  7. Intraindividual variation of microRNA expression levels in plasma and peripheral blood mononuclear cells and the associations of these levels with the pathogenesis of autoimmune thyroid diseases
  8. miRNA assays in the clinical laboratory: workflow, detection technologies and automation aspects
  9. Clinical Applications of the Different Circulating Forms of miRNAs
  10. The role of extracellular vesicle microRNAs in cancer biology
  11. The clinical significance of platelet microparticle-associated microRNAs
  12. microRNAs in lipoprotein and lipid metabolism: from biological function to clinical application
  13. microRNAs in cardiovascular disease – clinical application
  14. miRNAs in Cancer
  15. Non-coding RNAs: the cancer genome dark matter that matters!
  16. miRNAs as novel biomarkers in the management of prostate cancer
  17. Upregulated miR-16 expression is an independent indicator of relapse and poor overall survival of colorectal adenocarcinoma patients
  18. Identification of a novel microRNA, miR-4449, as a potential blood based marker in multiple myeloma
  19. miRNA analysis in pancreatic cancer: the Dartmouth experience
  20. miRNAs and Genomic
  21. miRNAs, single nucleotide polymorphisms (SNPs) and age-related macular degeneration (AMD)
Downloaded on 9.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2017-frontmatter5/html
Scroll to top button